## DAY: Dayforce, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -0.6% below STRENGTH zone (4.0-10.0%); PEG 5.36 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($68.77)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 74.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Price (T.Rowe) Assoc: 15.5% (-0.9%)
- Capital Internationa: 12.0% (-6.6%)
- Vanguard Group Inc: 10.8% (-1.7%)
- Edgepoint Investment: 10.7% (+5.5%)
- Blackrock Inc.: 6.6% (+7.9%)

### Key Risks

1. Valuation risk: PEG 5.4x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 5.36 signals overvaluation risk, limited margin of safety. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.1B |
| Beta | 1.20 |
| 52W Range | $48.01 - $75.14 |
| Short Interest | 6.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.36 |
| Forward P/E | 25.4 |
| Current P/E | 30.7 |
| YoY Growth | 20.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 4.6pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.11x) but short-term weakness (below SMA20). RSI neutral at 56. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.56% (CS: 40) | Neutral |
| RSI_14 | 55.6 | Neutral |
| MACD Histogram | -0.01 | Bearish |
| vs SMA20 | 1.000x | Below |
| vs SMA50 | 1.005x | Above |
| vs SMA200 | 1.113x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $69.15
- **Stop Loss:** $68.77 (0.5% risk)
- **Target:** $69.53 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 3157
- **Position Value:** $218,306.55
- **Portfolio %:** 218.31%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-11 (Est: $0.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.55 | $0.37 | -33.2% |
| 2025Q2 | $0.53 | $0.61 | +16.1% |
| 2025Q1 | $0.54 | $0.58 | +6.9% |
| 2024Q4 | $0.45 | $0.60 | +34.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*